FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
作者： Christophe Tournigand , Thierry André , Emmanuel Achille , Gérard Lledo , Michel Flesh
关键词:
摘要: Purpose In metastatic colorectal cancer, phase III studies have demonstrated the superiority of fluorouracil (FU) with leucovorin (LV) in combination with irinotecan or oxaliplatin over FU …
pubmed.cn参考文章(24)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Thierry André, Mohamed A. Bensmaine, Christophe Louvet, Eric François, Virginie Lucas, Françoise Desseigne, Karine Beerblock, Olivier Bouché, Elisabeth Carola, Yacine Merrouche, François Morvan, Ghislaine Dupont-André, Aimery de Gramont, Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen Journal of Clinical Oncology. ,vol. 17, pp. 3560- 3568 ,(1999) , 10.1200/JCO.1999.17.11.3560
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Bengt Glimelius, Katarina Hoffman, Wilhelm Graf, Lars Påhlman, Per-Olow Sjödén, , Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer Cancer. ,vol. 73, pp. 556- 562 ,(1994) , 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO;2-8
T André, C Louvet, F Maindrault-Goebel, C Couteau, M Mabro, J.P Lotz, V Gilles-Amar, M Krulik, E Carola, V Izrael, A de Gramont, CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer European Journal of Cancer. ,vol. 35, pp. 1343- 1347 ,(1999) , 10.1016/S0959-8049(99)00150-1
F Maindrault-Goebel, A De Gramont, C Louvet, T Andre, E Carola, M Mabro, P Artru, V Gilles, JP Lotz, V Izrael, M Krulik, Oncology Multidisciplinary Research Group, None, High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7) European Journal of Cancer. ,vol. 37, pp. 1000- 1005 ,(2001) , 10.1016/S0959-8049(01)00068-5
Stuart J. Pocock, Richard Simon, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Biometrics. ,vol. 31, pp. 103- 115 ,(1975) , 10.2307/2529712
Philippe Rougier, Eric Van Cutsem, Emilio Bajetta, Norbert Niederle, Kurt Possinger, Roberto Labianca, Matilde Navarro, Rudolf Morant, Harry Bleiberg, Jacques Wils, Lucile Awad, Patrice Herait, Christian Jacques, Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer The Lancet. ,vol. 352, pp. 1407- 1412 ,(1998) , 10.1016/S0140-6736(98)03085-2
E Raymond, C Buquet-Fagot, S Djelloul, J Mester, E Cvitkovic, P Allain, C Louvet, C Gespach, Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers Anti-Cancer Drugs. ,vol. 8, pp. 876- 885 ,(1997) , 10.1097/00001813-199710000-00009